The North American pancreatic stents market is witnessing growth driven by the increasing prevalence of pancreatic and biliary disorders, rising adoption of minimally invasive endoscopic procedures, and advancements in stent technologies. The presence of well-established healthcare infrastructure, specialized gastroenterology centers, and increasing demand for endoscopic retrograde...